[1]
Waqas Ahmad, “RECRYSTALLIZATION STRATEGIES FOR BIOPHARMACEUTICS CLASSIFICATION SYSTEM CLASS II DRUGS: IMPACT ON DISSOLUTION RATE AND ORAL BIOAVAILABILITY”, SES, vol. 4, no. 3, pp. 50–60, Mar. 2026.